- Recent Funding
- Investors
- Cornucopian Capital
Cornucopian Capital portfolio
Cornucopian Capital has 1 portfolio company on record at Recent Funding, with 1 investment in the last 12 months.
About this page
Its most recent investment on record is Excelsior Sciences's $70M Series A round in December 2025, alongside Khosla Ventures, Illinois Ventures, Eli Lilly and 3 others. That company is in Health and bio.
What Cornucopian Capital invests in
- Health and bio · 1 · 100%
- Manufacturing and industrial · 1 · 100%
How Cornucopian Capital invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series A | 1 100% | $70M |
Cornucopian Capital portfolio companies
EExcelsior Sciences$70MSeries A · Dec 2025
| Company | Round with Cornucopian Capital | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series A · $70M | $165M | Dec 3, 2025 Series A |
Most frequent co-investors
KKhosla Ventures1 shared round · last Dec 3, 2025
SSofinnova Partners1 shared round · last Dec 3, 2025
EEli Lilly1 shared round · last Dec 3, 2025
DDeerfield1 shared round · last Dec 3, 2025
IIllinois Ventures1 shared round · last Dec 3, 2025
- MMassachusetts Institute of Technology1 shared round · last Dec 3, 2025
Similar investors
IIzou Partners2 companies · 2 deals in 12 mo
- TThe Ljungstrom Family Office2 companies · 2 deals in 12 mo
OO'Shaughnessy Ventures3 companies · 1 deal in 12 mo
SSide Stage Ventures3 companies
AAble Partners4 companies · 1 deal in 12 mo
BBdc Thrive venture5 companies · 3 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Share is of the 1 round on Recent Funding that name Cornucopian Capital. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists Cornucopian Capital, which is a subset of its real portfolio. API: /api/v1/investors/cornucopian-capital (get a free API key). More: the most active VC firms and new venture capital funds.